First Opinion By Sumit Agarwal Physicians who refuse to accept Medicaid patients breach their contract with society
First Opinion By Wendy E. Parmet Trump’s immigration policies will make the coronavirus pandemic worse
Hospitals By Casey Ross and Andrew Joseph Mayo Clinic: Privately insured patients to get priority over Medicaid, Medicare patients
First Opinion By David Totaro Health aides’ low wages threaten home health care, a necessity for millions
Health By Megan Thielking Trump wants to cut $800 billion from Medicaid. Where does all the program’s money go?
First Opinion By Michael Hochman and Michelle Levander Create a scorecard to help make safety-net providers accountable to patients and the public
First Opinion By Divya Dethier, Megan L. Evans, and Erin Tracy Bradley Medicaid needs to change its archaic rules for women seeking permanent contraception
First Opinion By Eric Letsinger and Alison Rein Invest in community-based organizations to put health dollars where they are really needed
STAT+ Conversations By Casey Ross ‘I can’t imagine going back’: Medicare leader calls for expanded telehealth access after Covid-19
Pharmalot By Ed Silverman Mallinckrodt loses a court case and is on the hook for $650 million in overdue Medicaid rebates
First Opinion By Eric Schneider Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care
Pharmalot By Ed Silverman Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates
Pharmalot By Ed Silverman U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment
First Opinion By Maria Kefalas Medicaid covers sick or dying children. But it takes ‘going to battle’ to get it
First Opinion By Ira Byock and Eric Walsh Hopewell House hospice has closed. You should care about that
Politics By Priyanka Dayal McCluskey — Boston Globe and Matt Stout — Boston Globe Mass. governor — and one-time insurance executive — eyes a legacy-defining revamp of state’s health care
Pharmalot By Ed Silverman Pharmalittle: Five companies offer $50 billion deal to settle opioid suits; FDA approves record number of generics
Pharmalot By Ed Silverman Most state Medicaid programs continue to restrict access to hepatitis C medicines
Pharmalot By Ed Silverman A murky approach to tracking 340B drugs and Medicaid may yield double discounts in some states
Pharmalot By Ed Silverman Avanir to pay $116 million to settle bribery charges, while two docs and former sales reps are indicted
Pharmalot By Ed Silverman Mylan pays $30 million to settle charges of misleading investors over probe into EpiPen Medicaid rebates
Pharmalot By Ed Silverman Few Americans took obesity drugs thanks to doctor doubts and spotty insurance
First Opinion By Chuck Grassley Grassley: For Medicaid, greater transparency will open the door to better value and outcomes
Pharmalot By Ed Silverman Massachusetts lawmakers approve compromise bill to lower Medicaid drug spending
Pharmalot By Ed Silverman Pharmalittle: Trump abandons rebate rule; biotechs fume at Mass. governor’s plan to lower drug prices
Pharmalot By Ed Silverman Reckitt will pay $1.4 billion to settle federal probes into marketing of opioid-addiction treatment
Health By Ruth Hailu ‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care
Pharmalot By Ed Silverman Pharmalittle: Pfizer to buy Array for $11 billion, Teva settlement in Oklahoma may hit a new snag